GNMX
Aevi Genomic Medicine, Inc.
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
38 hedge funds and large institutions have $26.8M invested in Aevi Genomic Medicine, Inc. in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 1 closing their positions.
Holders
38
Holders Change
+14
Holders Change %
+58.33%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
10
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BC
1
Broadfin Capital
New York
|
$5.19M |
| 2 |
2
Jennison Associates
New York
|
$4.97M |
| 3 |
OM
3
Opaleye Management
Boston,
Massachusetts
|
$4.3M |
| 4 |
PA
4
Perceptive Advisors
New York
|
$2.6M |
| 5 |
SFM
5
Sphera Funds Management
Tel Aviv,
Israel
|
$1.14M |
